Concussion Health Improvement Program
Launched by SEATTLE CHILDREN'S HOSPITAL · Sep 6, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Concussion Health Improvement Program is a clinical trial aimed at helping young people aged 11 to 18 who are experiencing ongoing symptoms after a concussion. Each year, over a million youth in the U.S. suffer from concussions, and many experience long-term issues that can affect their daily lives, including their school performance and emotional well-being. This study is testing a new treatment approach combining therapy for the youth, skills training for parents, and care management, all delivered remotely through video calls. The goal is to see how effective these different components are in improving symptoms and overall quality of life for the participants.
To be eligible for the trial, young people must have been diagnosed with a concussion within the past year and report at least three new or worsening symptoms related to their concussion. The study is currently recruiting participants, and those who join can expect to take part in treatment sessions over three months while completing surveys to track their progress. This research is important because it aims to create a refined treatment program that can be widely used to support young individuals recovering from concussions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 11-18 years old
- • Health care provider diagnosed concussion within 1-12 months
- • ≥ 3 new onset or worsening post-concussive symptoms (measured with the HBI)
- • Can be located anywhere as study is all completed remotely
- Exclusion Criteria:
- • Active suicidal ideation, diagnosis of psychosis or psychiatric hospitalization within 6 months
- • Spinal cord injury or other severe injury or illness that might impede participation
- • Youth or parent not fluent in Spanish or English
- • Chronic illness or medical conditions that prevent participation in concussion-focused treatment
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Sara P Chrisman, MD MPH
Principal Investigator
Seattle Children's Hospital
Carolyn A McCarty, PhD
Principal Investigator
Seattle Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported